With Promising Data, Janssen To Ready Vaccine For Next Ebola Outbreak
Executive Summary
J&J says it will work with regulators to position its investigational Ebola Zaire vaccine for use in future outbreaks after publishing impressive Phase I prophylactic data in healthy volunteers.